PTEN and prostate carcinoma: Significantly, intracellular nanoparticle assisted delivery of recombinant PTEN protein has been successfully used in PTEN-deficient prostate cancer cell lines in vitro to reduce cell viability, and PTEN has been shown to accumulate at PC-3 xenografts in vivo using a nanoparticle delivery system [99,100].